Works by Balu, Sanjeev

Results: 34

Comparison of healthcare resource utilization and costs of patients with HR+/HER2- advanced breast cancer treated with ribociclib versus other CDK4/6 inhibitors.

Published in:

Journal of Medical Economics, 2021, v. 24, p. 806, doi. 10.1080/13696998.2021.1939705

By:

Burne, Rebecca;
Balu, Sanjeev;
Guérin, Annie;
Bungay, Rebecca;
Roxana Sin;
Paul, Mary Lisha

Publication type:

Article

Evaluation of access to care issues in patients with breast cancer.

Published in:

Journal of Medical Economics, 2021, v. 24, p. 38, doi. 10.1080/13696998.2020.1858580

By:

Brown, Carolyn M.;
Richards, Kristin M.;
Vohra, Yogesh;
Chisom Kanu;
Stevens, Laura;
Sasane, Rahul;
Balu, Sanjeev;
McAneny, Barbara

Publication type:

Article

Comparison of healthcare resource utilization and costs of patients with HR+/HER2- advanced breast cancer treated with ribociclib versus other CDK4/6 inhibitors.

Published in:

Journal of Medical Economics, 2021, v. 24, n. 1, p. 806, doi. 10.1080/13696998.2021.1939705

By:

Burne, Rebecca;
Balu, Sanjeev;
Guérin, Annie;
Bungay, Rebecca;
Sin, Roxana;
Paul, Mary Lisha

Publication type:

Article

Evaluation of access to care issues in patients with breast cancer.

Published in:

Journal of Medical Economics, 2021, v. 24, n. 1, p. 38, doi. 10.1080/13696998.2020.1858580

By:

Brown, Carolyn M.;
Richards, Kristin M.;
Vohra, Yogesh;
Kanu, Chisom;
Stevens, Laura;
Sasane, Rahul;
Balu, Sanjeev;
McAneny, Barbara

Publication type:

Article

Economic modeling for the US of the cost-efficiency and associated expanded treatment access of conversion to biosimilar pegfilgrastim-bmez from reference pegfilgrastim.

Published in:

2020

By:

McBride, Ali;
Wang, Weijia;
Campbell, Kim;
Balu, Sanjeev;
MacDonald, Karen;
Abraham, Ivo

Publication type:

journal article

Febrile neutropenia hospitalization due to pegfilgrastim on-body injector failure compared to single-injection pegfilgrastim and daily injections with reference and biosimilar filgrastim: US cost simulation for lung cancer and non-Hodgkin lymphoma.

Published in:

2020

By:

McBride, Ali;
Krendyukov, Andriy;
Mathieson, Nicola;
Campbell, Kim;
Balu, Sanjeev;
Natek, Maja;
MacDonald, Karen;
Abraham, Ivo

Publication type:

journal article

Impact of 5-HT3 receptor antagonists on chemotherapy-induced nausea and vomiting: a retrospective cohort study.

Published in:

2012

By:

Lin, Swu-Jane;
Hatoum, Hind T;
Buchner, Deborah;
Cox, David;
Balu, Sanjeev

Publication type:

journal article

Impact of 5-HT<sub>3</sub> receptor antagonists on chemotherapy-induced nausea and vomiting: a retrospective cohort study.

Published in:

2012

By:

Lin, Swu-Jane;
Hatoum, Hind T.;
Buchner, Deborah;
Cox, David;
Balu, Sanjeev

Publication type:

Case Study

Impact of initiating antiemetic prophylaxis with palonosetron versus ondansetron on risk of uncontrolled chemotherapy-induced nausea and vomiting in patients with lung cancer receiving multi-day chemotherapy.

Published in:

Supportive Care in Cancer, 2012, v. 20, n. 3, p. 615, doi. 10.1007/s00520-011-1140-x

By:

Feinberg, Bruce;
Gilmore, James;
Haislip, Sally;
Jackson, James;
Jain, Gagan;
Balu, Sanjeev;
Buchner, Deborah

Publication type:

Article

Use of advanced systemic therapy in patients with moderate-to-severe atopic dermatitis in the TARGET-DERM AD Registry.

Published in:

Current Medical Research & Opinion, 2024, v. 40, n. 12, p. 2057, doi. 10.1080/03007995.2024.2427883

By:

Haft, Michael A.;
Knapp, Keith D.;
Claxton, Ami;
Munoz, Breda;
Crawford, Julie M.;
Balu, Sanjeev;
Kim, Yestle;
Schneider, Shannon;
Eichenfield, Dawn Z.;
Silverberg, Jonathan I.;
Eichenfield, Lawrence F.;
Bagel, Jerry;
Rhoads, Jamie L. W.;
Paller, Amy S.

Publication type:

Article

Multiple sclerosis relapse rates and healthcare costs of two versions of glatiramer acetate.

Published in:

2020

By:

Greenberg, Benjamin;
Hall, Steven;
Grabner, Michael;
Balu, Sanjeev;
Zhang, Xian;
Kantor, Daniel

Publication type:

journal article

Reply: Cost-efficiency analyses for the US of biosimilar filgrastim-sndz, reference filgrastim, pegfilgrastim, and pegfilgrastim with on-body injector in the prophylaxis of chemotherapy-induced (febrile) neutropenia.

Published in:

Journal of Medical Economics, 2018, p. 606, doi. 10.1080/13696998.2018.1452749

By:

McBride, Ali;
Campbell, Kim;
Bikkina, Mohan;
MacDonald, Karen;
Abraham, Ivo;
Balu, Sanjeev

Publication type:

Article

The impact of initial statin treatment decisions on cardiovascular outcomes in clinical care settings: estimates using the Archimedes Model.

Published in:

ClinicoEconomics & Outcomes Research, 2012, v. 4, p. 337, doi. 10.2147/CEOR.S35487

By:

van Herick, Andrew;
Schuetz, C. Andy;
Alperin, Peter;
Bullano, Michael F.;
Balu, Sanjeev;
Gandhi, Sanjay

Publication type:

Article

Patient preferences for treatment attributes in moderate-to-severe atopic dermatitis: a discrete choice experiment.

Published in:

Journal of Dermatological Treatment, 2024, v. 35, n. 1, p. 1, doi. 10.1080/09546634.2024.2345739

By:

Feldman, Steven R.;
Guerin, Annie;
Gauthier-Loiselle, Marjolaine;
Claxton, Ami J.;
Hazra, Nisha C.;
Meng, Yan;
Gallant, Kirsten;
Balu, Sanjeev

Publication type:

Article

Cost-savings for biosimilars in the United States: a theoretical framework and budget impact case study application using filgrastim.

Published in:

2018

By:

Grewal, Simrun;
Ramsey, Scott;
Balu, Sanjeev;
Carlson, Josh J.

Publication type:

journal article

A Retrospective Managed Care Claims Data Analysis of Medication Adherence to Vaginal Estrogen Therapy: Implications for Clinical Practice.

Published in:

Journal of Women's Health (15409996), 2008, v. 17, n. 4, p. 569, doi. 10.1089/jwh.2007.0407

By:

Shulman, Lee P.;
Portman, David J.;
Won Chan Lee;
Balu, Sanjeev;
Joshi, Ashish V.;
Cobden, David;
Qin Wang;
Pashos, Chris L.

Publication type:

Article

714 - Real-world effectiveness of persistent tralokinumab use on clinician and patient-reported outcomes in patients with atopic dermatitis in the CorEvitas atopic dermatitis registry.

Published in:

British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.088

By:

Silverberg, Jonathan;
Balu, Sanjeev;
Choi, C Jean;
Li, Alvin;
Pugach, Oksana;
Schneider, Shannon;
Simpson, Eric

Publication type:

Article

713 - Real-world baseline characteristics and persistence in adult patients initiating tralokinumab in the CorEvitas atopic dermatitis registry.

Published in:

British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.087

By:

Simpson, Eric;
Balu, Sanjeev;
Choi, C Jean;
Li, Alvin;
Pugach, Oksana;
Schneider, Shannon;
Silverberg, Jonathan

Publication type:

Article

Tralokinumab real-world patient-reported outcomes in moderate-to-severe atopic dermatitis adult patients in the United States: 6-month interim analysis.

Published in:

British Journal of Dermatology, 2024, v. 190, p. ii50, doi. 10.1093/bjd/ljad498.052

By:

Lio, Peter;
Kim, Yestle;
Balu, Sanjeev;
Costantino, Halley;
Bates, Dawn;
Rene, Cassandra;
Lopez, Amanda;
Soung, Jennifer

Publication type:

Article

Clinical burden and work productivity impairment in moderate-to-severe atopic dermatitis patients in the United States.

Published in:

British Journal of Dermatology, 2024, v. 190, p. ii45, doi. 10.1093/bjd/ljad498.047

By:

Feldman, Steven R.;
Guerin, Annie;
Gauthier-Loiselle, Marjolaine;
Claxton, Ami J.;
Hazra, Nisha C.;
Yan Meng;
Gallant, Kirsten;
Balu, Sanjeev

Publication type:

Article

Patient preferences for treatment attributes in moderate-to-severe atopic dermatitis: a discrete choice experiment.

Published in:

British Journal of Dermatology, 2024, v. 190, p. ii44, doi. 10.1093/bjd/ljad498.046

By:

Feldman, Steven R.;
Guerin, Annie;
Gauthier-Loiselle, Marjolaine;
Hazra, Nisha C.;
Yan Meng;
Gallant, Kirsten;
Claxton, Ami J.;
Balu, Sanjeev

Publication type:

Article

Cost-per-responder analysis of tralokinumab versus dupilumab in patients with moderate-to-severe atopic dermatitis in the US and Canada.

Published in:

British Journal of Dermatology, 2024, v. 190, p. ii42, doi. 10.1093/bjd/ljad498.044

By:

Wu, Jashin J.;
Balu, Sanjeev;
Larsen, Nikolaj Birk;
Pulleyblank, Ryan;
Strømkjær, Liv;
Quah, Aron;
Wiseman, Marni

Publication type:

Article

405 Understanding patient experience and factors influencing patient preference in the treatment of moderate-to-severe atopic dermatitis through in-depth qualitative patient interviews.

Published in:

British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.027

By:

Feldman, Steven R;
Guerin, Annie;
Gauthier-Loiselle, Marjolaine;
Claxton, Ami J;
Meng, Yan;
Hazra, Nisha C;
Balu, Sanjeev

Publication type:

Article

372 Early insights into the characteristics of tralokinumab patients in a real-world setting in the United States.

Published in:

British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.003

By:

Chovatiya, Raj;
Balu, Sanjeev;
Kim, Yestle;
Althoff, Amanda G;
Rasouliyan, Lawrence

Publication type:

Article

Statin treatment patterns and clinical profile of patients with risk factors for coronary heart disease defined by National Cholesterol Education Program Adult Treatment Panel III.

Published in:

Current Medical Research & Opinion, 2014, v. 30, n. 12, p. 2443, doi. 10.1185/03007995.2014.971151

By:

Kern, David M.;
Balu, Sanjeev;
Tunceli, Ozgur;
Anzalone, Deborah

Publication type:

Article

Chemotherapy-induced nausea and vomiting and antiemetic prophylaxis with palonosetron versus other 5-HT3 receptor antagonists in patients with cancer treated with low emetogenic chemotherapy in a hospital outpatient setting in the United States.

Published in:

Current Medical Research & Opinion, 2011, v. 27, n. 8, p. 1613, doi. 10.1185/03007995.2011.596201

By:

Lee Schwartzberg;
Gary Morrow;
Sanjeev Balu;
Chris Craver;
Julie Gayle;
David Cox

Publication type:

Article

Likelihood of a subsequent chemotherapy-induced nausea and vomiting (CINV) event in patients receiving low, moderately or highly emetogenic chemotherapy (LEC/MEC/HEC)

Published in:

2011

By:

Lee Schwartzberg;
Stephen Szabo;
James Gilmore;
Sally Haislip;
James Jackson;
Gagan Jain;
Sanjeev Balu;
Deborah Buchner

Publication type:

Journal Article

Likelihood of a subsequent chemotherapy-induced nausea and vomiting (CINV) event in patients receiving low, moderately or highly emetogenic chemotherapy (LEC/MEC/HEC).

Published in:

Current Medical Research & Opinion, 2011, v. 27, n. 4, p. 837, doi. 10.1185/03007995.2011.556603

By:

Lee Schwartzberg;
Stephen Szabo;
James Gilmore;
Sally Haislip;
James Jackson;
Gagan Jain;
Sanjeev Balu;
Deborah Buchner

Publication type:

Article

Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence.

Published in:

Current Medical Research & Opinion, 2009, v. 25, n. 11, p. 2765, doi. 10.1185/03007990903297741

By:

Sanjeev Balu;
Robert J. Simko;
Ralph M. Quimbo;
Mark J. Cziraky

Publication type:

Article

Economic Analysis of Add--on Therapy with Thiazolidinedione (TZD) versus Insulin (INS) to Metformin (MET) Monotherapy.

Published in:

Diabetes, 2007, v. 56, p. A653

By:

Balu, Sanjeev;
Arondekar, Bhakti;
Lee, Won Chan;
Horblyuk, Ruslan;
Pashos, Chris L.

Publication type:

Article

Budgetary Impact of Thiazolidinedione (TZD) Add-On Therapy Relative to Insulin (INS) Add-On Therapy in Individuals Treated with Sulfonylureas (SU): A Third Party Payer's Perspective.

Published in:

Diabetes, 2007, v. 56, p. A653

By:

Balu, Sanjeev;
Arondekar, Bhakti;
Lee, Won Chan;
Horblyuk, Ruslan;
Pashos, Chris L.

Publication type:

Article

Insulin Administration Among Type 2 Diabetes Patients: Health Outcome and Economic Impact of Therapy Conversion to a Biphasic Insulin Analogue Pen.

Published in:

Diabetes, 2007, v. 56, p. A122

By:

Lee, Won Chan;
Balu, Sanjeev;
Cobden, David;
Joshi, Ashish;
Pashos, Chris

Publication type:

Article

Incremental Expenditure of Treating Hypertension in the United States

Published in:

American Journal of Hypertension, 2006, v. 19, n. 8, p. 810, doi. 10.1016/j.amjhyper.2005.12.013

By:

Balu, Sanjeev;
Thomas, Joseph

Publication type:

Article

Health Outcomes and Economic Impact of Therapy Conversion to a Biphasic Insulin Analog Pen Among Privately Insured Patients with Type 2 Diabetes Mellitus.

Published in:

Pharmacotherapy, 2007, v. 27, n. 7, p. 948, doi. 10.1592/phco.27.7.948

By:

Cobden, David;
Won Chan Lee;
Balu, Sanjeev;
Joshi, Ashish V.;
Pashos, Chris L.

Publication type:

Article